<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">kidney disease</z:e> is associated with a unique <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>, characterised by a combination of structural and cellular remodelling, and an enhanced susceptibility to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e>-reperfusion injury </plain></SENT>
<SENT sid="1" pm="."><plain>This may represent dysfunction of the reperfusion injury salvage kinase pathway, due to <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Aims: The susceptibility of the uraemic heart to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e>-reperfusion injury and the cardioprotective effects of insulin and <z:chebi fb="0" ids="50122">rosiglitazone</z:chebi> were investigated </plain></SENT>
<SENT sid="3" pm="."><plain>Methods and Results: <z:mp ids='MP_0009644'>Uraemia</z:mp> was induced in Sprague-Dawley rats by subtotal nephrectomy </plain></SENT>
<SENT sid="4" pm="."><plain>Functional recovery from <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> was investigated in vitro in control and uraemic hearts ±insulin ±<z:chebi fb="0" ids="50122">rosiglitazone</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>The response of myocardial oxidative metabolism to insulin was determined by <z:chebi fb="18" ids="36928">13C</z:chebi> NMR spectroscopy </plain></SENT>
<SENT sid="6" pm="."><plain>Activation of reperfusion injury salvage kinase pathway intermediates (Akt and GSK3β) were assessed by <z:chebi fb="26" ids="8984">SDS</z:chebi>-PAGE and immuno-precipitation </plain></SENT>
<SENT sid="7" pm="."><plain>Insulin improved post-ischaemic rate pressure product in control but not uraemic hearts, (recovered rate pressure product (%), control 59.6±10.7 vs 88.9±8.5, p&lt;0.05; uraemic 19.3±4.6 vs 28.5±10.4, p=ns) </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="0" ids="50122">Rosiglitazone</z:chebi> resensitised uraemic hearts to insulin-mediated cardio-protection (recovered rate pressure product (%) 12.7±7.0 vs. 61.8±15.9, p&lt;0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>Myocardial carbohydrate metabolism remained responsive to insulin in uraemic hearts </plain></SENT>
<SENT sid="10" pm="."><plain><z:mp ids='MP_0009644'>Uraemia</z:mp> was associated with increased phosphorylation of Akt (1.00±0.08 vs. 1.31±0.11, p&lt;0.05) in normoxia, but no change in post-ischaemic phosphorylation of Akt or GSK3β </plain></SENT>
<SENT sid="11" pm="."><plain>Akt2 isoform expression was decreased post-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> in uraemic hearts (p&lt;0.05) </plain></SENT>
<SENT sid="12" pm="."><plain>Conclusion: <z:mp ids='MP_0009644'>Uraemia</z:mp> is associated with enhanced susceptibility to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e>-reperfusion injury and a loss of insulin-mediated cardio-protection, which can be restored by administration of <z:chebi fb="0" ids="50122">rosiglitazone</z:chebi> </plain></SENT>
<SENT sid="13" pm="."><plain>Altered Akt2 expression in uraemic hearts post <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e>-reperfusion and impaired activation of reperfusion injury salvage kinase pathway may underlie these findings </plain></SENT>
</text></document>